EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular biology of microRNA-342 during tumor progression and invasion

Negin Taghehchian, Yalda Samsami, Amirhosein Maharati, Amir Sadra Zangouei, Samaneh Boroumand-Noughabi, Meysam Moghbeli

Pathology - Research and Practice · 2023-08 · 248 · 154672

DOI: 10.1016/j.prp.2023.154672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023-08. Verfasst von Negin Taghehchian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 211 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is considered as one of the main causes of human deaths and health challenges in the world. Various factors are involved in the high death rate of cancer patients, including late diagnosis and drug resistance that result in treatment failure and tumor recurrence. Invasive diagnostic methods are one of the main reasons of late tumor detection in cancer patients. Therefore, it is necessary to investigate the molecular tumor biology to introduce efficient non-invasive markers. MicroRNAs (miRNAs) are involved in regulation of the cellular mechanisms such as cell proliferation, apoptosis, and migration. MiRNAs deregulations have been also frequently shown in different tumor types. Here, we discussed the molecular mechanisms of miR-342 during tumor growth. MiR-342 mainly functions as a tumor suppressor by the regulation of transcription factors and signaling pathways such as WNT, PI3K/AKT, NF-kB, and MAPK. Therefore, miR-342 mimics can be used as a reliable therapeutic strategy to inhibit the tumor cells growth. The present review can also pave the way to introduce the miR-342 as a non-invasive diagnostic/prognostic marker in cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessDisease ProgressionBiomarkers, TumorSignal TransductionAnimalsCell Proliferation

Stichwörter der Autor:innen

CancerDiagnosisMicroRNA-342Non-invasive markerPrognosis

Substanzen

MicroRNAsMIRN342 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Hematology and Blood Bank, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir.

Zitieren

APA

Taghehchian, N., Samsami, Y., Maharati, A., Zangouei, A. S., Boroumand-Noughabi, S., & Moghbeli, M. (2023). Molecular biology of microRNA-342 during tumor progression and invasion. Pathology - Research and Practice, 248, 154672. https://doi.org/10.1016/j.prp.2023.154672

Vancouver

Taghehchian N, Samsami Y, Maharati A, Zangouei AS, Boroumand-Noughabi S, Moghbeli M. Molecular biology of microRNA-342 during tumor progression and invasion. Pathology - Research and Practice. 2023;248:154672. doi:10.1016/j.prp.2023.154672

BibTeX
@article{Taghehchian2023,
  author = {Taghehchian, Negin and Samsami, Yalda and Maharati, Amirhosein and Zangouei, Amir Sadra and Boroumand-Noughabi, Samaneh and Moghbeli, Meysam},
  title = {Molecular biology of microRNA-342 during tumor progression and invasion},
  journal = {Pathology - Research and Practice},
  year = {2023},
  volume = {248},
  pages = {154672},
  doi = {10.1016/j.prp.2023.154672}
}
Kostenlos starten →